β¨ Medicines Distribution Consents
NEW ZEALAND GAZETTE
No. 90
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Capril
Active Ingredient:
Captopril 12.5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada
Product:
Capril
Active Ingredient:
Captopril 25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada
Product:
Capril
Active Ingredient:
Captopril 50mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada
Product:
Wartec
Active Ingredient:
Podophyllotoxin 0.15%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
New Zealand Medical & Scientific Limited
Manufacturer:
Stiefel Laboratories (Ireland) Limited, Sligo, Ireland
Dated this 24th day of July 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5042
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Fasturtec
Active Ingredient:
Rasburicase 1.5mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Sanofi-Synthelabo (NZ) Limited
Manufacturer:
Sanofi Winthrop Industrie, Notre Dame de Bondeville, France
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 24th day of July 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5044
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the schedule hereto:
Schedule
Product:
Reach Harry Potter
Active Ingredient:
Sodium fluoride 0.2%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Johnson & Johnson Pacific New Zealand
Manufacturer:
Sheffield Laboratories, New London, Connecticut, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 90
Gazette.govt.nz —
NZ Gazette 2002, No 90
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare24 July 2002
Medicines, Distribution, Consent, Capril, Wartec, Captopril, Podophyllotoxin
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Provisional Consent to Distribution of New Medicine
π₯ Health & Social Welfare24 July 2002
Medicines, Provisional Consent, Distribution, Fasturtec, Rasburicase
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to Distribution of New Related Product
π₯ Health & Social Welfare24 July 2002
Medicines, Related Product, Distribution, Consent, Reach Harry Potter, Sodium fluoride
- G. R. Boyd, Chief Advisor, Safety and Regulation